Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.7B | 10.2B | 9.4B | 9.4B |
Cost of revenue | 5.2B | 4.5B | 4.2B | 4.1B |
Gross profit | 6.5B | 5.8B | 5.2B | 5.3B |
Operating expense | ||||
Research & development | 2.2B | 2.3B | 2.3B | 2.2B |
Selling general and admin | 723M | 761M | 664M | 707M |
Other operating expenses | — | — | — | — |
Operating income | 3.6B | 2.5B | 2.3B | 2.3B |
Non operating interest income | ||||
Income | 169M | 185M | 182M | 160M |
Expense | 163M | 180M | 168M | 172M |
Other income expense | 74M | 56M | -31M | 170M |
Pretax income | 3.6B | 2.6B | 2.3B | 2.5B |
Tax provision | 455M | -319M | 171M | 223M |
Net income | 3.2B | 2.9B | 2.1B | 2.3B |
Basic EPS | 2.9 | 2.6 | 1.9 | 2.1 |
Diluted EPS | 2.8 | 2.6 | 1.9 | 2.1 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 4.2B | 3.2B | 2.9B | 3.0B |
Net income from continuing op. | 3.2B | 2.9B | 2.1B | 2.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |